tiprankstipranks
Trending News
More News >

Acrux Director Increases Stake with New Share Acquisition

Story Highlights
  • Acrux Ltd operates in the pharmaceutical industry focusing on drug delivery solutions.
  • Director Don Brumley increased his stake by acquiring 448,334 shares, signaling confidence in Acrux.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Acrux Director Increases Stake with New Share Acquisition

Confident Investing Starts Here:

The latest announcement is out from Acrux ( (AU:ACR) ).

Acrux Ltd has announced a change in the interest of its director, Don Brumley, who has increased his holdings by acquiring 448,334 ordinary shares through the exercise of vested unlisted rights issued in 2024. This change reflects a strategic move by the director to increase his stake in the company, potentially signaling confidence in Acrux’s future performance and aligning his interests more closely with those of the shareholders.

More about Acrux

Acrux Ltd is a company operating in the pharmaceutical industry, focusing on the development and commercialization of innovative drug delivery solutions. The company primarily offers products that enhance the delivery of medications through the skin, targeting various therapeutic areas and aiming to improve patient outcomes.

Average Trading Volume: 271,212

Technical Sentiment Signal: Sell

Current Market Cap: A$9.78M

Find detailed analytics on ACR stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App